Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

Conditions:   COVID-19;   Liver Disease;   Vaccine Reaction Intervention:   Sponsors:   Hepatopancreatobiliary Surgery Institute of Gansu Province;   LanZhou University;   Huashan Hospital;   The Sixth People's Hospital of Shenyang City;   Xingtai City People's Hospital;   Jinchang Central Hospital;   Baoding People's Hospital;   The Third People's Hospital  of Zhenjiang City;   Shanxi Bethune Hospital;   Wuhan Jinyintan Hospital;   Jincheng People's Hospital;   The Third People's Hospital of Tibet Autonomous Region;   People's Hospital of Ningxia Hui Autonomous Region;   Fuling Central Hospital of Chongqing City;   Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region;   The Central Hospital of Lishui City;   The Third People's Hospital of Linfen City;   Yibin First People's Hospital;   Jingzhou Central Hospital;   Wuxi Fifth People's Hospital;   Qingyang People's Hos pital;   The First Affiliated Hospital of Anhui Medical University;   Beilun Hospital of Traditional Chinese Medicine;   Henan Provincial People's Hospital;   Qingdao Sixth People's Hospital;   The First Affiliated Hospital of Xiamen University;   Shandong Provincial Hospital;   Beijing YouAn Hospital;   The First People's Hospital of Taicang;   Taiyuan Third People's Hospital;   Tianjin Second People's Hospital;   Tianjin Third Central Hospital;   Qishan Hospi...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials